Petter Brodin is a dual-appointed academic with a Professor ship at Karolinska Institutet 's Department of Women's and Children's Health and a Senior Lecturer position at Imperial College London 's MRC London Institute of Medical Sciences. His work bridges clinical pediatrics and cutting-edge systems immunology , focusing on human immune system profiling through blood analysis. Education : MD/PhD from Karolinska Institutet, postdoc at Stanford University Research spans three major domains: Sex hormone immunomodulation - Revealing testosterone's role in suppressing autoimmune pathways while enhancing infection vulnerability through Nature studies of gender-affirming treatment Post-COVID pathophysiology - Developing antiviral treatment strategies for chronic SARS-CoV-2 reservoirs with Pfizer, focusing on severely affected patients Developmental immunology - Mapping immune-microbiome interactions in newborns and cancer immunotherapy applications in pediatric solid tumors Major awards include: 2023 Oscar Medin Prize 2024 Wallenberg Scholar 2022 VR and SSMF Consolidator Awards 2019 EMBO Young Investigator 2015 ERC Starting Grant Supervised 5 PhD/MSc students while leading a multidisciplinary team at BrodiN lab (brodinlab.com). Current clinical trials include: 15-day antiviral regimen for tissue reservoirs Immunomodulatory approaches for autoimmune profiles Active in science communication through BlueSky platform and Paris Kids Cancer Symposium leadership, emphasizing human-centric research over animal models.









